The successful launch of COVID-19 vaccines have been a strong driver of share price growth for some of the main players. AstraZeneca shares have risen 20% since the pandemic started. BioNTech has risen 600%. Moderna shares have gained 1000% and Novavax has gained over 2000%.
However, there are many smaller companies making progress with their own vaccine…